What happened in optometry this week: March 18 - March 22

Blog
Article

Catch up on what happened in optometry during the week of March 18-March 22.

Catch up with what Optometry Times shared this week:

OKYO Pharma announces additional statistically significant findings in results from Phase 2 trial of OK-101 (0.05%)

By Jordana Joy, Associate Editor

OKYO Pharma, a clinical-stage biopharmaceutical company, announced additional key findings from clinical data set analyses from its Phase 2 clinical trial evaluating the safety and efficacy of OK-101 (0.05%), an ophthalmic solution in patients with dry eye disease (DED), according to a news release.

Read here...

What you missed at Vision Expo East 2024

By Jordana Joy, Associate Editor

With Vision Expo East 2024 wrapping up its last year in New York City, the conference had plenty of the latest innovations in technology, treatment, glasses frames, and fashion on display.

Read here...

Myopia: An epidemic of global proportions

By Erin Tomiyama, OD, PhD, FAAO

Many current articles on myopia contain a citation to the 2016 study by Holden et al, which discusses the increasing prevalence of myopia worldwide.1 At the time of the study, approximately 23% of the world’s population had myopia, with a predicted increase to 50% by the year 2050. The highest prevalence rates were found in Asia-Pacific countries, with East Asia, Southeast Asia, and North America not far behind.1

Read here...

Faster epithelial healing for patients with corneal abrasion and PRK

By Leela V. Raju, MD

The recovery processes are similar for patients who present with a large corneal abrasion or undergo photorefractive keratectomy (PRK; laser ablation to remodel the corneal stroma). The wound is often very painful until the corneal epithelium has healed, which can take up to a week. Our goals are to control pain, prevent infection, and achieve epithelial healing as rapidly as possible, in turn further reducing infection risk and pain.

Listen here...

Going global: Improving vision care for Latino and Hispanic patients

By Diana Canto-Sims, OD

March 23, 2024, is designated as World Optometry Day. This presents an opportunity to appreciate expectations for and hurdles related to serving the rapidly-growing Hispanic and Latino populations in the United States.

Read here...

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.